Background: Routine health screening and monitoring declined when COVID-19 was declared a global pandemic on March 11, 2020. Early reports found Hemoglobin A1c (HbA1c) testing declined nearly 50% among patients with diabetes from March to May in 2020 compared with 2019. At-home sample collection aligns with social distancing practices and mitigates potential exposure to SARS-CoV-2 in public settings, including clinics. This study sought to characterize utilization of at-home lab tests and resulting HbA1c and lipid profiles in pre-pandemic and pandemic cohorts.

Methods: Results from individuals who used at-home collection to measure HbA1c, total cholesterol, calculated LDL-C, HDL, triglycerides, and hs-CRP between October 2017 and December 2020 were identified from a commercial consumer database. A total of 19,076 test-takers were included, of which 12,587 had HbA1c measurements and 13,624 had lipid measurements.

Results: Use of tests measuring HbA1c increased 60.3% in February-May 2020, around the time of pandemic declaration, and to a lesser degree from June-December when compared with 2019 use. Use of tests measuring lipids increased 61.9% during the same time periods. The mean HbA1c (%) in the pre-pandemic vs. pandemic cohort was 5.47 ± 0.72 (N = 3476) vs. 5.69 ± 0.87 (N = 2851) among users ages 18-44, 5.85 ± 1.04 (N = 2740) vs. 6.12 ± 1.17 (N = 1709) among users ages 45-64, and 6.05 ± 0.91 (N = 703) vs. 6.47 ± 1.34 (N = 513) among users ages 65+. Overall, the percent of individuals with an HbA1c characteristic of prediabetes and diabetes (HbA1c ≥ 5.7% and ≥ 6.5%, respectively) was 23.4% and 7.0% in 2018 (N = 2342), 26.6% and 8.5% in 2019 (N = 3751), and 38.8% and 14.7% of total users in 2020 (N = 6173).

Conclusions: The impact of the COVID-19 pandemic on at-home lab testing demonstrates the feasibility and increased usage of at-home sample collection for routine health monitoring particularly among people with elevated HbA1c.

Disclosure

E. J. Dion: Employee; Self; Everlywell, Inc.. D. Humphreys: None. K. Olds: Employee; Self; Everlywell, Inc. T. Siriwardhane: None. T. Bauer: Employee; Self; Everlywell, Inc.

© 2021 by the American Diabetes Association
2021
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.